Retro Biosciences

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

The artificial intelligence (AI) industry has been on a tear in the past two years, and judging by analyst estimates, it's just the beginning. AI-related sales will continue to soar in the coming years,

The arrival of big data, artificial intelligence (AI), and shared databases, offers unparallelled potential for advancing the study and treatment of rare diseases

As the CEO of Karyon Bio, Thirunagari introduced the company's ground breaking Digital Liver initiative, an AI-powered approach to tackling Metabolic Dysfunction-Associated Steatotic Liver Disease (MA

According to Rad AI, radiologists generate more than 700 million images per year in the United States alone and account for 80% of healthcare data. Collating and analyzing that data puts a tremendous burden on radiologists, which leads to an increasing issue among employees with burnout.

Sridevi Palepu's work redefines the landscape of immuno-hematology with advanced robotics, AI-driven precision, and user-focused design.

Trained on large databases of brain data among newborns, CergenX's Wave device uses AI to help with earlier detection of brain injury.

Plus: Blue Origin and SpaceX launch big rockets, how magnets could guide lasers to make better computers, how to best work with your IT department and more.